Showing results (3311-3320 of 3,354) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|June 22, 2021
Economic Evidence on Potentially Curative Gene Therapy Products: A Systematic Literature ReviewJoseph Khoa Ho, Kennedy Borle, Nick Dragojlovic, et al.Pharmacoeconomics|October 6, 2022
Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D InstrumentsAgata Łaszewska, Ayesha Sajjad, Jan Busschbach, et al.Pharmacoeconomics|November 15, 2022
The Costs of Dementia in Europe: An Updated Review and Meta-analysisLinus Jönsson, Ashley Tate, Oskar Frisell, et al.Pharmacoeconomics|March 6, 2007
Economic evaluations of cholesterol-lowering drugs: a critical and systematic reviewPearl D Gumbs, Monique W M Verschuren, Aukje K Mantel-Teeuwisse, et al.Pharmacoeconomics|September 5, 2008
Use of indirect and mixed treatment comparisons for technology assessmentAlex Sutton, A E Ades, Nicola Cooper, et al.Pharmacoeconomics|September 5, 2008
Valuing health States for use in cost-effectiveness analysisJohn BrazierPharmacoeconomics|May 21, 2008
Cost of epilepsy: a systematic reviewAdam Strzelczyk, Jens Peter Reese, Richard Dodel, et al.Pharmacoeconomics|September 18, 2009
Methods for measuring temporary health States for cost-utility analysesDavene R Wright, Eve Wittenberg, J Shannon Swan, et al.Pharmacoeconomics|April 10, 2009
The costs of treating breast cancer in the US: a synthesis of published evidenceJonathan D Campbell, Scott D RamseyPharmacoeconomics|January 14, 2010
Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the USJohn F P Bridges, Eberechukwu Onukwugha, C Daniel MullinsPageof 336